Skip to content

Clinical trials

Suspended Carcinoma, Non-Small-Cell Lung trials in China

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma, Non-Small-Cell Lung Status: Suspended Country / region: China Clear all

5 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20091
20131
20141
20181
20241

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Suspended5

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Betta Pharmaceuticals Co., Ltd.1
Jiangsu HengRui Medicine Co., Ltd.1
Tianjin Medical University Cancer Institute and Hospital1
Tongji Hospital1
Wondercel Biotech (ShenZhen)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma, Non-Small-Cell Lung5
Carcinoma, Hepatocellular1

Trials

Showing 1 to 5 of 5. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.